Acute respiratory distress syndrome in children

Current Opinion in Pediatrics

Volumn 9, Issue 3, 1997, Pages 207-212

  Beaufils, François ^a   Mercier, Jean Christophe ^a   Farnoux, Caroline ^a   Saizou, Carole ^a   Thébaud, Bernard ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LUNG SURFACTANT; LUNG SURFACTANT EXTRACT; NITRIC OXIDE; PERFLUOROOCTYL BROMIDE; SURFACTANT TA;

ADULT RESPIRATORY DISTRESS SYNDROME; AERATION; ARTIFICIAL VENTILATION; CLINICAL TRIAL; EXTRACORPOREAL OXYGENATION; HIGH FREQUENCY OSCILLATION; HUMAN; HYPERCAPNIA; INHALATIONAL DRUG ADMINISTRATION; MORTALITY; PEDIATRICS; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; REVIEW;

ANIMALS; CHILD; CLINICAL TRIALS; DISEASE MODELS, ANIMAL; EXTRACORPOREAL MEMBRANE OXYGENATION; FLUOROCARBONS; HIGH-FREQUENCY VENTILATION; HUMANS; NITRIC OXIDE; PEDIATRICS; POSITIVE-PRESSURE RESPIRATION; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY THERAPY;

EID: 0030849896     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-199706000-00003     Document Type: Review

References (47)

1. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE: Acute respiratory distress in adults. Lancet 1967, ii:319-323.
2. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, LeGall JR, Morris A, Spragg R: The Consensus Committee Report of the American European Consensus Conference on ARDS: definitions, mechanisms relevant outcomes and clinical trial coordination. Intensive Care Med 1994, 20:225-232.
3. Hyers TM: Adult respiratory distress syndrome: definition, risk factors, and outcome. In Adult Respiratory Distress Syndrome. Edited by Zapol WM, Lemaire F. New York: Dekker; 1991:23-26.
4. Bojko T, Notterman DA, Greenwald BM, de Bruin WJ, Magid MS, Godwin T: Acute hypoxemic respiratory failure in children following bone marrow transplantation: an outcome and pathologic study. Crit Care Med 1995, 23:755-759.
5. Garaventa A, Rendelli R, Castagnola E, Locatelli F, Dallorso S, Porta F, Uderzo C, Rossetti F, Miniero R, Andolina M, et al. for the Italian Association of Pediatric Hematology Oncology BMT Group. Fatal pneumopathy in children after bone marrow transplantation: report from the Italian Registry for Bone Marrow Transplantation. 1995, 16:669-674.
6. Randle CJ, Frankel LR, Amylon MO: Identifying early predictors of mortality in pediatric patients with acute leukemia and pneumonia. Chest 1996, 109:457-461.
7. Paulson TE, Spear RM, Peterson BM: New Concepts in the treatment of children with acute respiratory distress syndrome. J Pediatr 1995, 127:163-175. This is an extensive and excellent review covering many aspects of this topic, particularly the pathophysiology of the secondary lung injury and the ventilator strategies to minimize it.
8. Feihl F, Perret C: Permissive hypercapnia: how permissive should we be? Am J Respir Crit Care Med 1994, 150:1722-1737. This is an interesting discussion of all the aspects of permissive hypercapnia: effects of hypercapnia on the cardiocirculatory system, central nervous system, hepatic, intestinal, and renal circulation are discussed along with animal and human studies. The paper proposes a practical approach of the use of permissive hypercapnia.
9. Green TP, Moler FW, Goodman DM, for the Extracorporeal Life Support Organization. Crit Care Med 1995, 23:1132-1139.
10. Hickling KG, Walsh J, Henderson S, Jackson R: Low mortality rate in adult respiratory distess syndrom using low-volume pressure limited ventilation with permissive hypercapnia prospective study. Crit Care Med 1994, 22:1568-1578.
11. Sheridan RL, Kacmarek RM, Mc Ettrick NM, Weber JM, Ryan CM, Doody DP, Ryan DP, Schmitzer JJ, Tomphkins RG: Permissive hypercapnia as a ventilatory strategy in burned children: effect on barotrauma, pneumonia and mortality. J Trauma Care 1995, 39:254-259.
12. Paulson TE, Spear RM, Silva PD, Peterson BM: High frequency preschildren with acute respiratory syndrome. J Pediatr 1996, 129:566-573.
13. Slutzky AS: Pulmonary perspective: non conventional methods of ventilation. Am Rev Respir Dis 1988, 138:175-185.
14. Boussignac G, Labrune JC (inventors): Tube endotrachéal d'assistance respiratoire. French patent 1986, 86:06, 185.
15. Pinquier D, Pavlovic D, Boussignac G, Aubier M, Beaufils F: Benefits of the low pressure multichannel endotracheal ventilation. Am J Respir Crit Care Med 1996, 154:82-90. This interesting work describes an experimental study with a new technology of mechanical ventilation.
16. Dolan S, Derdak S, Salomon D, Farmer C, Johanningman J, Gelineau J, Smith RB: Tracheal gas insufflation combined with high frequency oscilatory ventilation. Crit Care Med 1996, 24:458-465.
17. Sarnaik AP, Meert KL, Pappas MD, Simpson PM, Lieh-Lai Mwn Heidemann SM: Predicting outcome in children with severe acute respiratory failure treated with high-frequency ventilation. Crit Care Med 1996, 24:1396-1402.
18. Arnold JH, Hanson JH Toro-Figuero LO, Gutierz J, Berens RJ, Anglin DL: Prospective randomized comparison of high frequency oscillatory ventilation and conventional mechanical ventilation in pediatric respiratory failure. Crit Care Med 1994, 22:1530-1539.
19. Morton A, Dalton H, Kochanek P, Janosky J, Thompson A: Extracorporeal membrane oxygenation for pediatric respiratory failure: five year experience at the University of Pittsburgh. Crit Care Med 1994, 22:1659-1667.
20. Caballero R, Clark RH, Wright JA: Outcome of respiratory failure: a case-control study. Clin Pediatr 1996, 35:199-204.
21. Moler FW, Palmisano J, Custer JR: Extracorporeal life support for pediatric respiratory failure: predictors of survival for 220 patients. Crit Care Med 1993, 21:1604-1611.
22. Arensman RM, Starter MB, Bastanrous AL, Madonna MB: Modern treatment modalities for neonatal and pediatric respiratory failure. Am J Surg 1996, 172:41-47.
23. Green TP, Timmons OD, Fackler JC, Moler FN, Thompson AE, Sweeney MF, for the Pediatric Critical Care Study Group: The impact of extracorporeal membrane oxygenation on survival in pediatric patients with acute respiratory failure. Crit Care Med 1996, 24:323-329. This paper is interesting because it concerns 331 patients evaluated during the same year of hospitalization, which is relatively rare in the ECMO cohorts.
24. Moler FW, Palmisano JM, Custer JR, Bartlett RH: Mechanical ventilation and arterial blood gas measurements 24 hours post extracorporeal life support for survivors of pediatric respiratory failure. Crit Care Med 1996, 24:679-678.
25. LeVine AM, Lotze A, Stanley S, Stroud C, O'Donnell R, Whitsett J, Pollack MM: Surfactant content in children with inflammatory lung disease. Crit Care Med 1996, 24:1062-1067. This paper documents abnormal tracheal aspirate surfactant phospholipids and surfactant protein A abnormalities in 60 children with bacterial pneumonia, viral pneumonitis, and ARDS, but not in 25 children on cardiopulmonary bypass nor in 35 controls. These data provide a clear rationale for exogenous surfactant therapy trials.
26. Suzuki H, Ohta T, Iwata K, Yagamuchi K, Sato T: Surfactant therapy for respiratory failure due to near-drowning. Eur J Pediatr 1996, 155:383-384.
27. Fraisse A, Paut O, Silicani MA, Viard L, Camboulives J: Intére̊t du surfactant exogène dans le traitement du syndrome de ditresse respiratoire aigüe de l'enfant. Arch Pédiatr 1996, 3:891-895.
28. Möller JC, Schaible TF, Reiss I, Artlich A, Gortner L: Treatment of severe non-neonatal ARDS in children with surfactant and nitric oxide in a "pre-ECMO"-situation. Int J Artific Org 1995, 18:598-602.
29. Willson DF, Jiao JH, Bauman LA, Zaritsky A, Craft H, Dockery K, Conrad D, Dalton H: Calf's lung surfactant extract in acute hypoxemic respiratory failure in children. Crit Care Med 1996, 24:1316-1322.
30. Anzueto A, Baugham RP, Guntupalli KK, Weg JG, Wiedemann HP, Raventos AA, Lemaire F, Long W, Zaccardelli DS, Pattishall EN, for the Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group: Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. N Engl J Med 1996, 334:1417-1421. This paper reports the largest prospective, multicenter, double-blind, placebocontrolled trial of exogenous surfactant in 725 adult patients with sepsis-induced ARDS. There was no significant effect on 30-day mortality, length of stay in the intensive care unit, duration of mechanical ventilation, or physiologic function. These negative results are carefully discussed.
31. Walmrath D, Günther A, Ghofrani HA, Schermuly R, Schneider T, Grimminger F, Seeger W: Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome and sepsis. Am J Respir Crit Care Med 1996, 154:57-62.
32. Papo MC, Paczan PR, Fuhrman BP, Steinhorn DM, Hernan LJ, Leach CL, Holm BA, Fisher JE, Kahn BA: Perfluorocarbon-associated gas exchange improves lung mechanics, and survival in a model of adult respiratory distress syndrome. Crit Care Med 1996, 24:466-474.
33. Hernan LJ, Fuhrman BP, Kaiser REJr, Penfil S, Foley C, Papo MC, Leach CL: Perfluorocarbon-associated gas exchange in normal and acid-injured large sheep. Crit Care Med 1996, 24:475-481.
34. Hirschl RB, Tooley R, Parent A, Johnson K, Bartlett RH: Evaluation of gas exchange, pulmonary compliance, and lung injury during total and partial liquid ventilation in the acute respiratory distress syndrome. Crit Care Med 1996, 24:1001-1008.
35. Tooley R, Hirschl RB, Parent A, Bartlett RH: Total liquid ventilation with perfluorocarbons increases pulmonary end-expiratory volume and compliance in the setting of lung atelectasis. Crit Care Med 1996, 24:268-273. This paper demonstrates that reexpansion of normal and saline-lavage surfactant-deficient atelectatic isolated cat lungs with total liquid ventilation was associated with a 11-fold increase in end-expiratory volume in comparison to gas ventilation. Thus, alveolar recruitment may be one of the main mechanisms by which gas exchanges are improved during total or partial liquid ventilation.
36. Tütüncü AS, Houmes RJM, Bos JAH, Wollmer P, Lachamann B: Evaluation of lung function after intratracheal perfluorocarbon administration in healthy animals. Crit Care Med 1996, 24:274-279.
37. Steinhorn DM, Leach CL, Fuhrman BP, Holm BA: Partial liquid ventilation enhances surfactant phospholipid production. Crit Care Med 1996, 24:1252-1256.
38. Hirshl RB, Pranikoff T, Gauger P, Schreiner RJ, Dechert R, Bartlett RH: Liquid ventilation in adults, children, and full-term neonates. Lancet 1995, 346:1201-1202.
39. Gauger PG, Pranikoff T, Schreiner RJ, Moler FW, Hirschl RB: Initial experience with partial liquid ventilation with the acute respiratory distress syndrome. Crit Care Med 1996, 24:16-22.
40. trn Multi-institutional Study Group: Peflubron partial liquid ventilation (PLV) in children with ARDS: a safety and efficacy pilot study [abstract]. Crit Care Med 1996, 24:A150.
41. Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM: Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991, 83:2038-2047.
42. Abman SH, Griebel JL, Parker DK, Schmidt JM, Swanton D, Kinsella JP: Acute effects of inhaled nitric oxide in children with severe hypoxemic respiratory failure. J Pediatr 1994, 124:881-888. This is the first and largest report on the acute effects of inhaled NO in 17 children with severe hypoxemic respiratory failure. Inhaled NO (20 ppm) acutely improved oxygenation in 15, who were subsequently treated with low doses (3 to 10 ppm) for 1 to 24 days. Survival was 100% in the six children with respiratory syncytial virus pneumonia, but only 50% in the 10 children with ARDS. Whether prolonged low-dose therapy can improve survival in ARDS remains to be proved by appropriate randomized clinical trials that are underway.
43. Day RW, Guarin M, Lynch JM, Vernon DD, Dean JM: Inhaled nitric oxide in children with severe lung disease: results of acute and prolonged therapy with two concentrations. Crit Care Med 1996, 24:215-221.
44. Mink RB, Ream RS, Hauver JF, Gale GB, Lynch RE: Inhaled nitric oxide improves oxygenation and ventilation in pediatric acute severe respiratory disease [abstract]. Crit Care Med 1996, 24:A148.
45. Rossetti M, Guénard H, Gabinski C: Effects of nitric oxide inhalation on pulmonary serial vascular resistances in ARDS. Am J Resp Crit Care Med 1996, 154:1375-1381.
46. Benzing A, Bräutigam P, Geiger K, Loop T, Beyer U, Moser E: Inhaled nitric oxide reduces pulmonary transvascular albumin flux in patients with acute lung injury. Anesthesiology 1995, 83:1153-1161.
47. 2 release by polynuclear neutrophils in bronchoalveolar lavage fluid recovered from adult patients with ARDS exposed to inhaled NO, as compared to the control subjects. Likewise, the high levels of interleukins IL-6 and IL-8 were reduced in BAL fluid after NO inhalation, but not in the control subjects.